共 264 条
[1]
Ansaloni L(2012)Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer Int J Gynecol Cancer 22 778-785
[2]
Agnoletti V(2012)Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study Ann Surg Oncol 19 1416-1424
[3]
Amadori A(2011) comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin) Cancer Chemother Pharmacol 68 1001-1008
[4]
Catena F(2013)Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis Eur J Clin Pharmacol 69 533-540
[5]
Cavaliere D(2012)Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study Ann Oncol 23 647-652
[6]
Coccolini F(2009)The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma Neoplasia 11 1155-1164
[7]
De Iaco P(1999)Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis J Clin Pharmacol 39 394-401
[8]
Di Battista M(2012)Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome Int J Colorectal Dis 27 381-389
[9]
Framarini M(2013)Criticalities in randomized controlled trials on HIPEC for ovarian cancer World J Obstet Gynecol 2 124-128
[10]
Gazzotti F(2014)Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials Eur J Surg Oncol 40 12-26